← All medicines
Cabergoline 500 micrograms Tablets
Licence PA22865/014/001 · Not marketed
- Licence holder
- Renata Pharmaceuticals (Ireland) Limited (all products →)
- Active substance
- Cabergoline
- Dosage form
- Film-coated tablet
- Route of administration
- Oral use
- ATC code
- G02CB03
- First authorised
- 11/10/2024
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- Generic application (Article 10(1) of Directive No 2001/83/EC)
Data: Health Products Regulatory Authority (HPRA) open dataset, licensed CC BY 4.0, published 04 Jul 2026. This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.